{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:13:36Z","timestamp":1791893616954,"version":"4.3.4"},"reference-count":56,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Qatar University Collaborative Research Grant","award":["QUCG-CPH-25\/26-782"],"award-info":[{"award-number":["QUCG-CPH-25\/26-782"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background\/Objectives: Understanding the patterns of inappropriate antibiotic prescribing is crucial to design antimicrobial stewardship interventions. This systematic review evaluated the prevalence and types of inappropriate antibiotic prescribing among dialysis patients. Methods: Four electronic bibliographic databases including PubMed, Embase, Scopus, and CINAHL, were searched. Supplementary search was conducted using Google Scholar and by manually checking the reference list of selected studies. Selected studies include those published in the English language since inception of the databases until October 2024. Two independent reviewers screened, selected, and extracted the data for qualitative synthesis. Results: Of the 784 records identified from the databases, 13 studies fulfilled the eligibility criteria. Eight of the studies (42.6%) were from the USA. Antibiotic prescribing rate ranging from 16 to 75.5% was reported among dialysis patients, with vancomycin (6.5\u2013100%), piperacillin-tazobactam (2.4\u201344.5%), meropenem (2.1\u201325.8%), metronidazole (2.1\u201316.4%), cefazolin (4.3\u201313.6%), and ceftriaxone (1.3\u201310.8%) being the most commonly prescribed antibiotics. The studies showed that 20\u201365.7% of prescriptions are inappropriate, mostly due to inappropriate dosing (25.5\u2013100%), lack of an indication (5.5\u201373.9%), and inappropriate choice\/spectrum (23.6\u201369.7%). Conclusions: Antibiotic prescribing among dialysis population is higher than the rate reported among hospitalized patients. High rate of broad-spectrum antibiotic prescribing coupled with the high rate of inappropriate antibiotic prescribing indicate the need for the implementation of antimicrobial stewardship programs in dialysis settings.<\/jats:p>","DOI":"10.3390\/antibiotics14101049","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T15:20:12Z","timestamp":1760973612000},"page":"1049","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence and Types of Inappropriate Antibiotics Prescribing Among Dialysis Patients: A Systematic Review"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6220-7355","authenticated-orcid":false,"given":"Sara","family":"Abul-Ola","sequence":"first","affiliation":[{"name":"College of Pharmacy, QU Health, Qatar University, Doha P.O. Box 2713, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2986-8156","authenticated-orcid":false,"given":"Reem","family":"Alenany","sequence":"additional","affiliation":[{"name":"College of Pharmacy, QU Health, Qatar University, Doha P.O. Box 2713, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Abubakar","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Practice, College of Pharmacy, QU Health, Qatar University, Doha P.O. Box 2713, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/ki.2011.368","article-title":"The contribution of chronic kidney disease to the global burden of major noncommunicable diseases","volume":"80","author":"Couser","year":"2011","journal-title":"Kidney Int."},{"key":"ref_3","unstructured":"Bello, A.K., Okpechi, I.G., Levin, A., Ye, F., Saad, S., Zaidi, D., Houston, G., Damster, S., Arruebo, S., and Abu-Alfa, A. (2023). A report by the International Society of Nephrology: An assessment of global kidney health care status focussing on capacity, availability, accessibility, affordability and outcomes of kidney disease. ISN\u2013Global Kidney Health Atlas, International Society of Nephrology."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ackd.2018.09.003","article-title":"Prevention and treatment of multidrug-resistant organisms in end-stage renal disease","volume":"26","author":"Midturi","year":"2019","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1038\/s41598-020-59794-7","article-title":"Infection in advanced chronic kidney disease and subsequent adverse outcomes after dialysis initiation: A nationwide cohort study","volume":"10","author":"Chang","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/sdi.12094","article-title":"Multidrug-resistant organisms in dialysis patients","volume":"26","author":"Calfee","year":"2013","journal-title":"Semin. Dial."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: A global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog. Glob. Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00239-019-09914-3","article-title":"Antimicrobial resistance in bacteria: Mechanisms, evolution, and persistence","volume":"88","author":"Christaki","year":"2020","journal-title":"J. Mol. Evol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/ajkd.2002.36332","article-title":"Preventing bacterial infections and antimicrobial resistance in dialysis patients","volume":"40","author":"Berns","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/MNH.0000000000000281","article-title":"Implementing an antimicrobial stewardship program in out-patient dialysis units","volume":"25","author":"Cunha","year":"2016","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Abubakar, U., Zulkarnain, A.I., Rodr\u00edguez-Ba\u00f1o, J., Kamarudin, N., Elrggal, M.E., Elnaem, M.H., and Harun, S.N. (2022). Treatments and predictors of mortality for carbapenem-resistant Gram-negative bacilli infections in Malaysia: A retrospective cohort study. Trop. Med. Infect. Dis., 7.","DOI":"10.3390\/tropicalmed7120415"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/j.ackd.2018.10.006","article-title":"Antibiotic dosing in chronic kidney disease and end-stage renal disease: A focus on contemporary challenges","volume":"26","author":"Vilay","year":"2019","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1060028019865873","article-title":"Antibiotic dosing for critically ill adult patients receiving intermittent hemodialysis, prolonged intermittent renal replacement therapy, and continuous renal replacement therapy: An update","volume":"54","author":"Hoff","year":"2020","journal-title":"Ann. Pharmacother."},{"key":"ref_14","first-page":"457","article-title":"Antimicrobial use and stewardship programs among dialysis centers","volume":"26","year":"2013","journal-title":"InSeminars Dial."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12882-017-0575-9","article-title":"Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodialysis: An observational study","volume":"18","author":"Hui","year":"2017","journal-title":"BMC Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/875512250201800303","article-title":"Antibiotic prescribing evaluation in an outpatient hemodialysis clinic","volume":"18","author":"Manley","year":"2002","journal-title":"J. Pharm. Technol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1086\/669869","article-title":"Antimicrobial use in outpatient hemodialysis units","volume":"34","author":"Snyder","year":"2013","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/875512251302900403","article-title":"Compliance with antibiotic dosing guidelines in critically ill patients receiving renal replacement therapy","volume":"29","author":"Udani","year":"2013","journal-title":"J. Pharm. Technol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/0897190013519679","article-title":"Compliance with institutional antimicrobial dosing guidelines in patients receiving continuous venovenous hemodialysis","volume":"28","author":"Fedorenko","year":"2015","journal-title":"J. Pharm. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.2042-7174.2012.00226.x","article-title":"Evaluation of antibiotic prescribing patterns in patients receiving sustained low-efficiency dialysis: Opportunities for pharmacists","volume":"21","author":"Harris","year":"2013","journal-title":"Int. J. Pharm. Pract."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s11096-018-0697-6","article-title":"Inadequate antibiotic dosing in patients receiving sustained low efficiency dialysis","volume":"40","author":"Keough","year":"2018","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e4493-8","DOI":"10.1093\/cid\/ciaa1801","article-title":"Outpatient antibiotic prescribing patterns for adult end-stage renal disease patients in New York state","volume":"73","author":"Coritsidis","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0272-6386(00)70303-9","article-title":"Vancomycin prescribing practices in hospitalized chronic hemodialysis patients","volume":"35","author":"Green","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4212\/cjhp.v75i1.3250","article-title":"Patterns of antimicrobial use in an outpatient hemodialysis unit","volume":"75","author":"Sivarajahkumar","year":"2022","journal-title":"Can. J. Hosp. Pharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1093\/ndt\/gfn343","article-title":"Assessment of vancomycin use in chronic haemodialysis patients: Room for improvement","volume":"23","author":"Zvonar","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jsps.2022.05.005","article-title":"Antibiotics utilization patterns and dosage appropriateness among patients receiving hemodialysis","volume":"30","author":"Abdelrahman","year":"2022","journal-title":"Saudi Pharm. J."},{"key":"ref_27","first-page":"1327","article-title":"spectrum of infections assessment of antibiotic use in maintenance hemodialysis patients","volume":"11","author":"Saradhi","year":"2020","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"ref_28","first-page":"1811222","article-title":"Antimicrobial use in European acute care hospitals: Results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017","volume":"47","author":"Plachouras","year":"2018","journal-title":"Euro Surveill."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1053\/j.ajkd.2020.08.011","article-title":"Opportunities to improve antibiotic prescribing in outpatient hemodialysis facilities: A report from the American Society of Nephrology and Centers for Disease Control and Prevention Antibiotic Stewardship White Paper Writing Group","volume":"77","author":"Apata","year":"2021","journal-title":"Am. J. Kidney Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1001\/jama.2014.12923","article-title":"Ray Prevalence of antimicrobial use in US acute care hospitals, May-September 2011","volume":"312","author":"Magill","year":"2014","journal-title":"JAMA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00431-019-03560-z","article-title":"Prevalence and predictors of antibiotic use among children visiting the Emergency Department in a Tertiary Hospital in Malaysia","volume":"179","author":"Tham","year":"2020","journal-title":"Eur. J. Pediatr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1017\/ash.2023.525","article-title":"Intermittent hemodialysis: A review of the top antimicrobial stewardship practices to be employed","volume":"4","author":"Shamas","year":"2024","journal-title":"Antimicrob. Steward. Healthc. Epidemiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jhin.2017.05.018","article-title":"Epidemiology of infections and antimicrobial use in Australian haemodialysis outpatients: Findings from a Victorian surveillance network, 2008\u20132015","volume":"97","author":"Worth","year":"2017","journal-title":"J. Hosp. Infect."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"18003","DOI":"10.1038\/s41598-022-21979-7","article-title":"Patterns of microbial resistance in bloodstream infections of hemodialysis patients: A cross-sectional study from Palestine","volume":"12","author":"AbuTaha","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ajic.2016.03.034","article-title":"Factors associated with the receipt of antimicrobials among chronic hemodialysis patients","volume":"44","author":"Snyder","year":"2016","journal-title":"Am. J. Infect. Control."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1298858","DOI":"10.3389\/fmicb.2023.1298858","article-title":"WHO AWaRe classification for antibiotic stewardship: Tackling antimicrobial resistance\u2013a descriptive study from an English NHS Foundation Trust prior to and during the COVID-19 pandemic","volume":"14","author":"Elshenawy","year":"2023","journal-title":"Front. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2024.02.003","article-title":"WHO\u2032s essential medicines and AWaRe: Recommendations on first-and second-choice antibiotics for empiric treatment of clinical infections","volume":"30","author":"Moja","year":"2024","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1007\/s40615-023-01610-9","article-title":"Antibiotic use among hospitalized patients in Africa: A systematic review of point prevalence studies","volume":"11","author":"Abubakar","year":"2024","journal-title":"J. Racial Ethn. Health Disparities"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"101871","DOI":"10.1016\/j.eclinm.2023.101871","article-title":"Risk factors for infections caused by carbapenem-resistant Enterobacterales: An international matched case-control-control study (EURECA)","volume":"57","author":"Paniagua","year":"2023","journal-title":"EClinicalMedicine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1093\/jac\/dkae157","article-title":"Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: A nested case-control-control study","volume":"79","author":"Zhou","year":"2024","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cmi.2020.10.016","article-title":"Risk factors for carbapenem-resistant Gram-negative bacterial infections: A systematic review","volume":"27","author":"Giannella","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_43","unstructured":"Centers for Diseases Control and Prevention (CDC) (2019). Core Elements of Hospital Antibiotic Stewardship Programs, US Department of Health and Human Services, CDC. Available online: https:\/\/www.cdc.gov\/antibiotic-use\/hcp\/core-elements\/hospital.html."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6506a1","article-title":"Core elements of outpatient antibiotic stewardship","volume":"65","year":"2016","journal-title":"MMWR. Recomm. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/FTD.0000000000000941","article-title":"Therapeutic drug monitoring of antibiotic drugs in patients receiving continuous renal replacement therapy or intermittent hemodialysis: A critical review","volume":"44","author":"Matusik","year":"2022","journal-title":"Ther. Drug Monit."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/CCM.0b013e318206c3b2","article-title":"Antibiotic dosing during sustained low-efficiency dialysis: Special considerations in adult critically ill patients","volume":"39","author":"Bogard","year":"2011","journal-title":"Crit. Care Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13054-015-0818-8","article-title":"A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics","volume":"19","author":"Roberts","year":"2015","journal-title":"Crit. Care"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ejim.2014.08.001","article-title":"Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment","volume":"25","author":"Jiang","year":"2014","journal-title":"Eur. J. Intern. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jgar.2019.10.007","article-title":"Nationwide survey of pharmacists\u2019 involvement in antimicrobial stewardship programs in Nigerian tertiary hospitals","volume":"21","author":"Abubakar","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_50","first-page":"1152","article-title":"Nigerian pharmacists\u2032 self-perceived competence and confidence to plan and conduct pharmacy practice research","volume":"16","author":"Abubakar","year":"2018","journal-title":"Pharm. Pract."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12941-016-0143-3","article-title":"Comparative effectiveness of \u03b2-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia","volume":"15","author":"Wong","year":"2016","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/cid\/civ308","article-title":"Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals","volume":"61","author":"McDanel","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_53","first-page":"511","article-title":"Advancing Antimicrobial Stewardship in Outpatient Dialysis Centers Using the Positive Deviance Process","volume":"46","author":"Lindberg","year":"2019","journal-title":"Nephrol. Nurs. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1017\/ice.2018.237","article-title":"The positive effects of an antimicrobial stewardship program targeting outpatient hemodialysis facilities","volume":"39","author":"Lindberg","year":"2018","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"ref_55","first-page":"372","article-title":"PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews","volume":"29","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/10\/1049\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T15:33:20Z","timestamp":1760974400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/10\/1049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":56,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["antibiotics14101049"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics14101049","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]}}}